Project Details
| Acronym | CS1001/Regorafenib-101 |
|---|---|
| Status | Not started |
A phase Ib/II multicenter open-label study of CS1001 in combination with regorafenib in patients with advanced or refractory solid tumors
- Park, John (Primary Chief Investigator)
- Gurney, Howard (Associate Investigator)
- Parshionikar, Abhijit (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Rai, Meenal (Clinical Trial Unit Staff)
Project: Research